Patent Assignment
Reel/Frame 022390/0234
Merger
Recorded: 2009-03-13
Received: 2009-03-13
Pages: 7
Assignor
KIRIN PHARMA CO., LTD.
Executed: 2008-10-01
Assignee
KYOWA HAKKO KIRIN CO., LTD.
1-6-1, OHTEMACHI, CHIYODA-KU, TOKYO, JPX, JAPAN
Covered Properties
(31)
Anti-A33 Antibody
Application:
12/053,461 →
Polypeptide Having an Activity to Support Proliferation or Survival of Hematopoietic Stem or Progenitor Cells
Application:
10/512,109 →
Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene and Non-Human Animal Containing the Human Artificial Chromosome Capable of Genetic Transmission
Application:
11/151,227 →
Transgenic Animals and Uses Thereof
Application:
11/111,310 →
N-{2-Chloro-4-[(6,7-Dimethoxy-4-Quinolyl)Oxy]Phenyl}-N'-(5-Methyl-3-Isoxazolyl)Urea Salt in Crystalline Form
Application:
10/532,104 →
Stem Cell Growth Factor-Like Polypeptides
Application:
10/968,674 →
Polypeptide Having an Activity to Support Proliferation or Survival of Hematopoietic Stem Cell and Hematopoietic Progenitor Cell, and Dna Coding for the Same
Application:
10/478,926 →
Quinoline Derivatives and Quinazoline Derivatives Having Azolyl Group
Application:
10/861,446 →
Quinoline Derivatives and Quinazoline Derivatives
Application:
10/842,009 →
Compounds, Derivatives, Compositions, Preparation and Uses
Application:
10/486,239 →
Transgenic Bovines Capable of Human Antibody Production
Application:
10/441,503 →
Nitrogen-Containing Compounds Having Kinase Inhibitory Activity and Drugs Containing the Same
Application:
10/181,943 →
Polynucleotides Encoding Stem Cell Growth Factor-Like Polypeptides
Application:
10/168,365 →
Nkt Cell-Activating Agents Containing Alpha-Glycosylceramides
Application:
10/334,861 →
Calcium Receptor-Active Compounds
Application:
10/326,713 →
Novel Isoxazole and Thiazole Compounds and Use Thereof as Medicine
Application:
10/204,173 →
Quinoline Derivatives and Quinazoline Derivatives Having Azolyl Group
Application:
10/132,473 →
Calcium Receptor-Active Compounds
Application:
10/053,133 →
Compounds and Their Use
Application:
09/996,776 →
Transgenic Transchromosomal Rodents for Making Human Antibodies
Application:
10/000,433 →
Transgenic Bovine Comprising Human Immunoglobulin Loci and Producing Human Immunoglobulin
Application:
09/988,115 →
Stem Cell Growth Factor-Like Polypeptides
Application:
09/912,935 →
Quinoline Derivatives and Quinazoline Derivatives
Application:
09/889,858 →
Substituted 4,9-Dihydrocyclopent a [Imn] Phenanthridine-5-Ones, Derivatives Thereof and Their Uses
Application:
09/895,262 →
Method of Promoting Stem Cell Proliferation or Survival by Contacting a Cell with a Cell Factor-Like Polypeptide
Application:
09/894,912 →
Methods, compounds and compositions for treating gout
Application:
09/870,782 →
Sulfonamide and Carbamide Derivatives of 6(5H)Phenanthridinones and Their Uses
Application:
09/854,455 →
Human Anti-CD40 Antibodies
Application:
09/844,684 →
Method for Modifying Chromosomes
Application:
09/763,362 →
Compounds, Methods and Pharmaceutical Compositions for Treating Cellular Damage, Such as Neural or Cardiovascular Tissue Damage
Application:
09/781,195 →
Stem Cell Growth Factor-Like Polypeptide
Application:
09/764,325 →